First, a brief history of time in the Europe Union (EU).
It goes slowly.
For the last two years or so the European Commission has been consulting on plans to revise the European Clinical Trials Directive. The Directive has been in force since 2001. Researchers hate it. To be fair so do many patient organisations. The main complaint is that it slows down research into new drugs particularly in swotty Britain where we tend to do everything by the book and then bind it in gold leaf. That’s probably because of a) our schooling, b) we are brought up as subjects and, c) because of the same tendencies that make us enjoy queuing (select from the above as you see fit).
Over the summer the Commission published a draft proposal for new legislation or ‘Regulation’ for consultation and it is being considered by the European Parliament. Cue…
View original post 380 more words